4320 related articles for article (PubMed ID: 4133186)
21. Combination chemotherapy in vitro. III. BCNU.
Drewinko B; Loo TL; Freireich EJ
Cancer Treat Rep; 1979 Mar; 63(3):373-5. PubMed ID: 427819
[No Abstract] [Full Text] [Related]
22. Cell population kinetics - experimental methods and their in vivo relevance for human cancer chemotherapy.
Hill BT; Whelan RD; Rupniak HT; Price LA
Arch Geschwulstforsch; 1981; 51(1):103-10. PubMed ID: 7259432
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
Spreafico F; Mantovani A
Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
[No Abstract] [Full Text] [Related]
24. The immunology of tumors.
Burk MW; Mckhann CF
Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
[No Abstract] [Full Text] [Related]
25. Kinetic behavior versus response to chemotherapy.
Skipper HE
Natl Cancer Inst Monogr; 1971 Dec; 34():2-14. PubMed ID: 4946581
[No Abstract] [Full Text] [Related]
26. Drug activity and therapeutic synergism in cancer treatment.
Carter WH; Wampler GL; Stablein DM; Campbell ED
Cancer Res; 1982 Aug; 42(8):2963-71. PubMed ID: 6807534
[TBL] [Abstract][Full Text] [Related]
27. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
Bach ML; Bach FH; Zoschke DC
Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
[No Abstract] [Full Text] [Related]
28. [Testing the sensitivity of malignant tumors to cytostatics in vitro and in vivo. Methods and clinical experiences].
Wüst GP
Munch Med Wochenschr; 1973 May; 115(18):839-42. PubMed ID: 4800216
[No Abstract] [Full Text] [Related]
29. Responses of cycling and noncycling cells to 1,3-bis(2-chloroethyl)-1-nitrosourea and to bleomycin.
Hahn GM; Gordon LF; Kurkjian SD
Cancer Res; 1974 Sep; 34(9):2373-7. PubMed ID: 4135685
[No Abstract] [Full Text] [Related]
30. The immunology of cancer.
Angel Basombrío M
J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
[No Abstract] [Full Text] [Related]
31. Marrying immunotherapy with chemotherapy: why say IDO?
Muller AJ; Prendergast GC
Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
[TBL] [Abstract][Full Text] [Related]
32. Immunochemotherapy of cancer.
Br Med J; 1972 Aug; 3(5825):486-7. PubMed ID: 5069613
[No Abstract] [Full Text] [Related]
33. [Correlation of in vitro testing and therapeutical results in animal transplanted tumors after cytostatic treatment].
Wayss K; Mattern J; Volm M
Arzneimittelforschung; 1975 Jan; 25(1):77-81. PubMed ID: 50072
[TBL] [Abstract][Full Text] [Related]
34. An overview of the status of the nitrosoureas in other tumors.
Carter SK
Cancer Chemother Rep 3; 1973 May; 4(3):35-46. PubMed ID: 4584034
[No Abstract] [Full Text] [Related]
35. [Immunology and cancer].
Brunner KT
Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090
[No Abstract] [Full Text] [Related]
36. In vivo synchrony of solid B16 melanoma by cytosine arabinoside, an inhibitor of DNA synthesis.
Gibson MH; Bertalanffy FD
J Natl Cancer Inst; 1972 Oct; 49(4):1007-18. PubMed ID: 5084119
[No Abstract] [Full Text] [Related]
37. [Longitudinal studies on cellular immunity in patients with neoplasms].
Spengler H; Brunner KW; de Weck A
Schweiz Med Wochenschr; 1972 Aug; 102(33):1167-9. PubMed ID: 5055036
[No Abstract] [Full Text] [Related]
38. Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases.
Tsuruo T; Fidler IJ
Cancer Res; 1981 Aug; 41(8):3058-64. PubMed ID: 7248962
[TBL] [Abstract][Full Text] [Related]
39. [A review of experimental thermochemotherapy in cultured cells].
Furuya M; Kano E
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2083-90. PubMed ID: 2415066
[TBL] [Abstract][Full Text] [Related]
40. The immunology of cancer: avenues to immunotherapy.
Woods AH
Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
